Australian researchers have developed a new way to synthesise bicyclic peptides, which they claim is more reliable and more accessible than current methods. It could help future research into drug treatments for a range of diseases, including cancer and viral and bacterial infections.
A monoclonal antibody administered under the skin of healthy adults protected them against malaria in a small study carried out in the US. The researchers are hopeful that injecting antibodies into people may not only stop infection but also limit transfer of the parasite to others, via mosquitoes.
Researchers have revealed a new experimental medicine that could offer hope for sufferers of the autoimmune disease lupus. Affecting 5m people worldwide, symptoms include rashes, fatigue and organ deterioration that can lead to death. While there is no cure, current treatments can help disease management.
Read all the latest news about the movers and shakers in the chemical industry for September 2022.